Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan-Feb;29(1):84-85.
doi: 10.1177/12034754241287553. Epub 2024 Sep 25.

Clinical Characteristics and Treatment Patterns of Pityriasis Rubra Pilaris: A Canadian Retrospective Study

Affiliations

Clinical Characteristics and Treatment Patterns of Pityriasis Rubra Pilaris: A Canadian Retrospective Study

Iryna Savinova et al. J Cutan Med Surg. 2025 Jan-Feb.
No abstract available

Keywords: biologic; papulosquamous; pityriasis rubra pilaris; retrospective study; treatment.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting InterestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: MAH received honorariums, served as a speaker and/or advisor for AbbVie, Boehringer Ingelheim, Bristol Myers Squibb, Galderma, Janssen, Leo, Lilly, L’Oreal, Medexus, Novartis, Pfizer, Sanofi, Sun Pharma. AC has served on advisory boards, received honourariums, or contributed to clinical trials for AbbVie, Amgen, Aralez Pharmaceuticals, Bausch Health, Celgene Corporation, Eli Lilly, Galderma, Janssen, Johnson and Johnson, LEO Pharma, Novartis, Pfizer, Sanofi, UCB, and Valeant. MG has served as investigator/consultant or speaker for AbbVie, Akros Pharma, Amgen, Arcutis Biotherapeutics, Aslan, Aristea, Anaptys-Bio, Bausch, BMS, Boehringer Ingelheim, Coherus BioSciences, Dermira, Dermavant, Eli Lilly, Galderma, GSK, Incyte, Inmagene, Janssen, Kyowa Kirin, LEO Pharma, MedImmune, Meiji, Merck, Moonlake, Nimbus, Novartis, Pfizer, Regeneron Pharmaceuticals, Reistone, Roche, Sanofi, Sun Pharma, Takeda, Tarsus, Union, UCB, and Ventyx. AO received honourariums, served as a speaker, and/or advisor, or contributed to clinical trials for AbbVie, Boehringer Ingelheim, Bristol Myers Squibb, Galderma, Janssen, Leo, Lilly, Novartis, Pfizer, Sanofi, Sun Pharma, Amgen, Bausch Health, UCB, Incyte, Moonlake, Nimbus, and Ventyx. MB and IS have no conflict of interest to declare. No conflicts of interest affected the study’s validity/outcome.

LinkOut - more resources